{"id":"https://openalex.org/W1567073283","doi":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","title":"Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide","display_name":"Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide","publication_year":2011,"publication_date":"2011-07-14","ids":{"openalex":"https://openalex.org/W1567073283","doi":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","mag":"1567073283","pmid":"https://pubmed.ncbi.nlm.nih.gov/21740412","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3346252"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.2011.01585.x","doi":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2011.01585.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2011.01585.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048991357","display_name":"Nathalie Fretellier","orcid":"https://orcid.org/0000-0002-4551-422X","observed_orcids":["https://orcid.org/0000-0002-4551-422X"]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"N Fretellier","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France. nathalie.fretellier@guerbet-group.com","Chimie Toxicologie Analytique et Cellulaire, EA 4463, Faculte\u0301 des Sciences Pharmaceutiques et Biologiques, Universite\u0301 Paris Descartes, Paris, France,","Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France. nathalie.fretellier@guerbet-group.com","institution_ids":["https://openalex.org/I120615911"]},{"raw_affiliation_string":"Chimie Toxicologie Analytique et Cellulaire, EA 4463, Faculte\u0301 des Sciences Pharmaceutiques et Biologiques, Universite\u0301 Paris Descartes, Paris, France,","institution_ids":["https://openalex.org/I4387156284"]},{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111572470","display_name":"JM Id\u00e9e","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"JM Id\u00e9e","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028555797","display_name":"Patrick Bruneval","orcid":"https://orcid.org/0000-0002-2350-2914","observed_orcids":["https://orcid.org/0000-0002-2350-2914"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210102325","display_name":"H\u00f4pital Europ\u00e9en Georges-Pompidou","ror":"https://ror.org/016vx5156","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102325","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4210131199","display_name":"Paris Cardiovascular Research Center","ror":"https://ror.org/03gvnh520","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210131199"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P Bruneval","raw_affiliation_strings":["Department of Pathology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France","INSERM U970, Department of Pathology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France","institution_ids":["https://openalex.org/I4210102325"]},{"raw_affiliation_string":"INSERM U970, Department of Pathology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210102325","https://openalex.org/I4210131199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068295841","display_name":"Sylviane Gu\u00e9rret","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Guerret","raw_affiliation_strings":["Novotec, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novotec, Lyon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081464545","display_name":"Florence Daubin\u00e9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Daubin\u00e9","raw_affiliation_strings":["Atlantic Bone Screen, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atlantic Bone Screen, Nantes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089859394","display_name":"Ga\u00eblle Jestin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G Jestin","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065874712","display_name":"C\u00e9cile Factor","orcid":"https://orcid.org/0000-0003-0904-8716","observed_orcids":["https://orcid.org/0000-0003-0904-8716"]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Factor","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112913265","display_name":"Nathaly Poveda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N Poveda","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014787055","display_name":"Anne Dencausse","orcid":"https://orcid.org/0000-0003-4665-0837","observed_orcids":["https://orcid.org/0000-0003-4665-0837"]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A Dencausse","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065789310","display_name":"France Massicot","orcid":"https://orcid.org/0000-0003-0831-1236","observed_orcids":["https://orcid.org/0000-0003-0831-1236"]},"institutions":[{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F Massicot","raw_affiliation_strings":["Chimie Toxicologie Analytique et Cellulaire, EA 4463, Faculte\u0301 des Sciences Pharmaceutiques et Biologiques, Universite\u0301 Paris Descartes, Paris, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chimie Toxicologie Analytique et Cellulaire, EA 4463, Faculte\u0301 des Sciences Pharmaceutiques et Biologiques, Universite\u0301 Paris Descartes, Paris, France,","institution_ids":["https://openalex.org/I4387156284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044518822","display_name":"Olivier Lapr\u00e9v\u00f4te","orcid":"https://orcid.org/0000-0001-9825-4831","observed_orcids":["https://orcid.org/0000-0001-9825-4831"]},"institutions":[{"id":"https://openalex.org/I4210119095","display_name":"H\u00f4pital Lariboisi\u00e8re","ror":"https://ror.org/02mqtne57","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210119095"]},{"id":"https://openalex.org/I4387156284","display_name":"Universit\u00e9 Paris Descartes","ror":"https://ror.org/0220k9r37","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387156284"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"O Lapr\u00e9vote","raw_affiliation_strings":["Chimie Toxicologie Analytique et Cellulaire, EA 4463, Faculte\u0301 des Sciences Pharmaceutiques et Biologiques, Universite\u0301 Paris Descartes, Paris, France,","Service de Toxicologie Biologique, Ho\u0302pital Lariboisie\u0300re, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chimie Toxicologie Analytique et Cellulaire, EA 4463, Faculte\u0301 des Sciences Pharmaceutiques et Biologiques, Universite\u0301 Paris Descartes, Paris, France,","institution_ids":["https://openalex.org/I4387156284"]},{"raw_affiliation_string":"Service de Toxicologie Biologique, Ho\u0302pital Lariboisie\u0300re, Paris, France","institution_ids":["https://openalex.org/I4210119095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066322468","display_name":"Chantal Mandet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210102325","display_name":"H\u00f4pital Europ\u00e9en Georges-Pompidou","ror":"https://ror.org/016vx5156","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102325","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4210131199","display_name":"Paris Cardiovascular Research Center","ror":"https://ror.org/03gvnh520","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210131199"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Mandet","raw_affiliation_strings":["INSERM U970, Department of Pathology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U970, Department of Pathology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210102325","https://openalex.org/I4210131199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069054485","display_name":"Nejma Bouzian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N Bouzian","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003655871","display_name":"Marc Port","orcid":"https://orcid.org/0000-0001-9870-859X","observed_orcids":["https://orcid.org/0000-0001-9870-859X"]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Port","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016040044","display_name":"Claire Corot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I120615911","display_name":"Guerbet (France)","ror":"https://ror.org/0504sxa76","country_code":"FR","type":"company","lineage":["https://openalex.org/I120615911"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C Corot","raw_affiliation_strings":["Guerbet, Research Division, Aulnay-sous-Bois, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guerbet, Research Division, Aulnay-sous-Bois, France","institution_ids":["https://openalex.org/I120615911"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5048991357"],"corresponding_institution_ids":["https://openalex.org/I120615911","https://openalex.org/I4387156284"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.109,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.73675118,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"165","issue":"4b","first_page":"1151","last_page":"1162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11279","display_name":"Lanthanide and Transition Metal Complexes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11279","display_name":"Lanthanide and Transition Metal Complexes","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperphosphatemia","display_name":"hyperphosphatemia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/nephrogenic-systemic-fibrosis","display_name":"nephrogenic systemic fibrosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/gadodiamide","display_name":"gadodiamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/gadolinium-based-contrast-agents","display_name":"gadolinium-based contrast agents","score":0.9869999885559082},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.6370000243186951},{"id":"https://openalex.org/keywords/subtotal-nephrectomy","display_name":"subtotal nephrectomy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/relaxometry","display_name":"relaxometry","score":0.5569999814033508},{"id":"https://openalex.org/keywords/skin-fibrosis","display_name":"skin fibrosis","score":0.7360000014305115},{"id":"https://openalex.org/keywords/high-phosphorus-diet","display_name":"high-phosphate diet","score":0.7620000243186951},{"id":"https://openalex.org/keywords/gadolinium-toxicity","display_name":"gadolinium toxicity","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C2780026267","wikidata":"https://www.wikidata.org/wiki/Q2031078","display_name":"Gadodiamide","level":3,"score":0.956343412399292},{"id":"https://openalex.org/C2781027423","wikidata":"https://www.wikidata.org/wiki/Q677803","display_name":"Nephrogenic systemic fibrosis","level":3,"score":0.8735946416854858},{"id":"https://openalex.org/C557651011","wikidata":"https://www.wikidata.org/wiki/Q1832","display_name":"Gadolinium","level":2,"score":0.6086903810501099},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5764048099517822},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5379958748817444},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.527228832244873},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.4332837462425232},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3927454948425293},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.35594409704208374},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.15807798504829407},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003287","descriptor_name":"Contrast Media","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005269","descriptor_name":"Femur","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005682","descriptor_name":"Gadolinium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005682","descriptor_name":"Gadolinium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011393","descriptor_name":"Procollagen-Proline Dioxygenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019715","descriptor_name":"Tissue Inhibitor of Metalloproteinase-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019786","descriptor_name":"Gadolinium DTPA","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019786","descriptor_name":"Gadolinium DTPA","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054559","descriptor_name":"Hyperphosphatemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D054559","descriptor_name":"Hyperphosphatemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D054559","descriptor_name":"Hyperphosphatemia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054989","descriptor_name":"Nephrogenic Fibrosing Dermopathy","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D054989","descriptor_name":"Nephrogenic Fibrosing Dermopathy","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D054989","descriptor_name":"Nephrogenic Fibrosing Dermopathy","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1476-5381.2011.01585.x","doi":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2011.01585.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3481442","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3346252","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:21740412","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21740412","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3346252","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3346252/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.2011.01585.x","doi":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2011.01585.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.2011.01585.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1567073283.pdf","grobid_xml":"https://content.openalex.org/works/W1567073283.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W131398339","https://openalex.org/W263068934","https://openalex.org/W1569584988","https://openalex.org/W1588625263","https://openalex.org/W1963655497","https://openalex.org/W1969547991","https://openalex.org/W1969964865","https://openalex.org/W1978587722","https://openalex.org/W1980480613","https://openalex.org/W1981154575","https://openalex.org/W1983021880","https://openalex.org/W1985044581","https://openalex.org/W1991739011","https://openalex.org/W1992800232","https://openalex.org/W1994191978","https://openalex.org/W1995365986","https://openalex.org/W1999260980","https://openalex.org/W2004288850","https://openalex.org/W2007481188","https://openalex.org/W2019842087","https://openalex.org/W2020783600","https://openalex.org/W2031641614","https://openalex.org/W2031692079","https://openalex.org/W2034909082","https://openalex.org/W2037832318","https://openalex.org/W2039220271","https://openalex.org/W2039503809","https://openalex.org/W2039511738","https://openalex.org/W2043070144","https://openalex.org/W2049464509","https://openalex.org/W2050928977","https://openalex.org/W2053790124","https://openalex.org/W2054326242","https://openalex.org/W2060437861","https://openalex.org/W2061948232","https://openalex.org/W2064173076","https://openalex.org/W2065581510","https://openalex.org/W2066263439","https://openalex.org/W2088386521","https://openalex.org/W2097958959","https://openalex.org/W2103813652","https://openalex.org/W2109768646","https://openalex.org/W2110213842","https://openalex.org/W2126686566","https://openalex.org/W2133793934","https://openalex.org/W2140170550","https://openalex.org/W2143340697","https://openalex.org/W2143482279","https://openalex.org/W2150489367","https://openalex.org/W2154131284","https://openalex.org/W2160898068","https://openalex.org/W2165391836","https://openalex.org/W2313764594","https://openalex.org/W2316661712","https://openalex.org/W2326830868","https://openalex.org/W2328699588"],"related_works":["https://openalex.org/W2083129012","https://openalex.org/W2142716296","https://openalex.org/W2010191338","https://openalex.org/W1963447972","https://openalex.org/W7098018741","https://openalex.org/W1969547991","https://openalex.org/W2103813652","https://openalex.org/W2326830868","https://openalex.org/W1990106926","https://openalex.org/W2007772778"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,223],"PURPOSE:":[2],"Hyperphosphataemia":[3,225],"is":[4,47,251],"common":[5],"in":[6,61,78,107,116,133,148,181,194,214,244],"patients":[7],"with":[8,185,212],"nephrogenic":[9],"systemic":[10],"fibrosis":[11],"(NSF).":[12],"NSF":[13,54],"has":[14],"been":[15],"linked":[16],"to":[17,139,144,230],"administration":[18,86],"of":[19,32,59,74,87,102,156,219,234],"gadolinium":[20],"(Gd)":[21],"chelates":[22],"(GCs)":[23],"and":[24,71,119,130,150,168,171,190,217],"elevated":[25],"serum":[26],"phosphate":[27],"levels":[28],"accelerate":[29],"the":[30,57,68,88,100,187,195,201,207,231,237],"release":[31,218],"Gd":[33,114,147],"from":[34],"linear,":[35],"non-ionic":[36],"GCs":[37,104,189,239],"but":[38],"not":[39],"macrocyclic":[40],"GCs.":[41],"Hence,":[42],"we":[43],"determined":[44],"whether":[45],"hyperphosphataemia":[46,60,75,250],"a":[48,161,252],"cofactor":[49],"or":[50,193],"risk":[51,253],"factor":[52,254],"for":[53,255],"by":[55,123,135],"investigating":[56],"role":[58],"renally":[62,227],"impaired":[63,228],"rats.":[64,112],"EXPERIMENTAL":[65],"APPROACH:":[66],"Firstly,":[67],"clinical,":[69],"pathological":[70],"bioanalytical":[72],"consequences":[73],"were":[76,105,179],"investigated":[77],"subtotal":[79],"nephrectomized":[80],"(SNx)":[81],"Wistar":[82],"rats":[83,159,183,229],"following":[84],"i.v.":[85],"non-ionic,":[89],"linear":[90],"GC":[91],"gadodiamide":[92,165,204,241],"(5":[93],"\u00d7":[94],"2.5":[95],"mmol\u00b7kg(-1)":[96],"\u00b7day(-1)":[97],").":[98],"Secondly,":[99],"effects":[101,233],"several":[103],"compared":[106],"these":[108],"high-phosphate":[109,162],"diet":[110,163],"fed":[111,160],"Total":[113],"concentration":[115],"skin,":[117],"femur":[118],"plasma":[120,126,134],"was":[121,142],"measured":[122],"inductively":[124],"coupled":[125,138],"mass":[127],"spectrometry":[128],"(ICP-MS)":[129],"free":[131,191],"Gd(3+)":[132],"liquid":[136],"chromatography":[137],"ICP-MS.":[140],"Relaxometry":[141],"used":[143],"measure":[145],"dissociated":[146],"skin":[149,173,177],"bone.":[151],"KEY":[152],"RESULTS:":[153],"Four":[154],"out":[155],"seven":[157],"SNx":[158,182],"administered":[164],"developed":[166],"macroscopic":[167],"microscopic":[169],"(fibrotic":[170],"inflammatory)":[172],"lesions,":[174],"whereas":[175],"no":[176],"lesions":[178],"observed":[180],"treated":[184],"saline,":[186],"other":[188,202,238],"ligands":[192],"normal":[196],"diet,":[197],"gadodiamide-treated":[198],"group.":[199],"Unlike":[200,236],"molecules,":[203],"gradually":[205,242],"increased":[206],"r(1)":[208],"relaxivity":[209],"value,":[210],"consistent":[211],"its":[213],"vivo":[215],"dissociation":[216],"soluble":[220],"Gd.":[221],"CONCLUSIONS":[222],"IMPLICATIONS:":[224],"sensitizes":[226],"profibrotic":[232],"gadodiamide.":[235],"investigated,":[240],"dissociates":[243],"vivo.":[245],"Our":[246],"data":[247],"confirm":[248],"that":[249],"NSF.":[256]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}